HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High risk human papillomavirus at entry to prenatal care and risk of preeclampsia.

AbstractOBJECTIVE:
To determine the association between high-risk human papillomavirus (HR-HPV) and preeclampsia.
METHODS:
Retrospective cohort study of women with HR-HPV at entry to prenatal care compared with those with at least 2 normal pap smears. Preeclampsia was defined by clinical guidelines. Unadjusted and adjusted analyses were performed.
RESULTS:
Three hundred fourteen women with HR-HPV matched with 628 women with normal pap smears. Exposed HR-HPV patients were younger, had lower body mass index, systolic and diastolic blood pressure at entry to care, and more likely to be nulliparous and smokers. Exposed HR-HPV patients were more likely to develop preeclampsia (10.19% vs 4.94%; P = .004; adjusted odds ratio, 2.18; 95% confidence interval, 1.31-3.65). Women with HR-HPV were also more likely to deliver prematurely at less than 37 and less than 35 weeks.
CONCLUSION:
HR-HPV is associated with an almost 2-fold increased risk of developing preeclampsia. This warrants a larger study, particularly when HPV infection can be prevented with vaccination.
AuthorsMollie McDonnold, Holly Dunn, Ashley Hester, Luis D Pacheco, Gary D V Hankins, George R Saade, Maged M Costantine
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 210 Issue 2 Pg. 138.e1-5 (Feb 2014) ISSN: 1097-6868 [Electronic] United States
PMID24096182 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Mosby, Inc. All rights reserved.
Topics
  • Adult
  • Age Factors
  • Female
  • Humans
  • Papillomavirus Infections (complications)
  • Parity
  • Pre-Eclampsia (etiology)
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Prenatal Care
  • Retrospective Studies
  • Risk Factors
  • Smoking (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: